As per the latest Sun Pharma news, the US Food and Drug Administration (USFDA) which happens to be the US based arm of Aurobindo Pharma is reported to being recalled s many as 1,15,776 bottles of Moxifloxacin Ophthalmic Solution which is basically an antibiotic used to treat various bacterial infections.
Leading pharma companies like Aurobindo Pharma and Sun pharma are currently recalling a number of products in the dominant US market mainly due to the recent deviation from heir standard manufacturing guidelines.
Sun Pharma News: Aurobindo, Sun Pharma Recall Products In US Market
As per the latest advisory issued by the US Food and Drug Administration (USFDA), Aurobindo Pharma is known to recalling as many as 1,15,776 bottles of Moxifloxacin Ophthalmic Solution which is an antibiotic used to treat various bacterial infections.
It further adds that the Princeton-based Aurobindo Pharma is currently recalling the affected lot mainly due to the failed impurities or due to degradation specifications.
Also Read: Over Half of U.S. Abortions Now Done With Abortion Pills
%20which%20happens%20to%20be%20the%20US%20based%20arm%20of%20Aurobindo){kind=link}